1. A 5-Pathway Signature Predicts Prognosis Based on Immune-Derived lncRNAs in Patients with Breast Cancer. (12th December 2022) Authors: Liu, Bo; Zhu, Nian; Huo, Huixia; Long, Junqi; Ji, Xinchan; Li, Jinmeng; Zhuang, Xujie; Wang, Huina; Li, Lujia; Chen, Yuhaoran; Yang, Wei; Zhao, Shuangtao Other Names: Qin Shuanglin Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Lower HCC Incidence in Chronic HBV-Infected Patients Recovered from Acute-on-Chronic Liver Failure: A Prospective Cohort Study. (27th October 2022) Authors: Yin, Jianhua; Xu, Xiang; Pu, Rui; Su, Haibin; Wang, Junxue; Liu, Wenbin; Tong, Jingjing; Chen, Jing; Chen, Xi; Mu, Xiuying; Zhang, Hongwei; Zhai, Xingran; Liu, Xiaoyan; Pang, Fei; Wang, Yu; Wang, Huifen; Cao, Guangwen; Hu, Jinhua Other Names: Qin Shuanglin Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma. (12th September 2022) Authors: Wang, Xuequan; Meng, Yinnan; Liu, Changxin; Yang, Haihua; Zhou, Suna Other Names: Qin Shuanglin Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Activated Mast Cells Combined with NRF2 Predict Prognosis for Esophageal Cancer. (4th January 2023) Authors: Guo, Xinxin; Shen, Weitao; Sun, Mingjun; Lv, Junjie; Liu, Ran Other Names: Qin Shuanglin Academic Editor. Journal: Journal of oncology Issue: Volume 2023(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Computational Drug Repurposing Approach to Identify Novel Inhibitors of ILK Protein for Treatment of Esophageal Squamous Cell Carcinoma. (29th December 2022) Authors: Liu, Juan; Ma, Xiaoli; Cao, Leiyu; Wei, Yu; Gao, Yan; Qu, Chengcheng; Maimaitiming, Nuersimanguli; Zhang, Li Other Names: Qin Shuanglin Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges. (9th November 2022) Authors: Huang, Ao; Chen, Jia-Feng; Wu, Jian-Zhang; Gao, Zheng; Shi, Ying-Hong; Fu, Xiu-Tao; Zhang, Xin; Liu, Wei-Ren; Gao, Qiang; Sun, Hui-Chuan; Shi, Guo-Ming; Fan, Jia; Ding, Zhen-Bin; Zhou, Jian Other Names: Qin Shuanglin Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identification of Melanoma Subsets Based on DNA Methylation Sites and Construction of a Prognosis Evaluation Model. (11th October 2022) Authors: Tengda, Li; Cheng, Qian; Yi, Sun Other Names: Qin Shuanglin Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals. (4th November 2022) Authors: Fukuchi, Keisuke; Nanai, Kayoko; Yuita, Hiroshi; Maru, Chikako; Tsukada, Jun; Ishigami, Masato; Nagai, Yoko; Nakano, Yoko; Yoshimura, Chigusa; Yoneda, Kozo; Amano, Masato; Nakamura, Kensuke; Oda, Yoko; Nishigohri, Haruyuki; Yamamoto, Shoji; Ohnishi-Totoki, Yusuke; Inaki, Koichiro; Komori, Hironob... Other Names: Qin Shuanglin Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Novel Gene Signatures Promote Epithelial-Mesenchymal Transition (EMT) in Glucose Deprivation-Based Microenvironment to Predict Recurrence‐Free Survival in Hepatocellular Carcinoma. (21st February 2023) Authors: Huang, Yuan; Li, Shi-Rong; Gao, Ying-Jie; Zhu, Yan-hua; Zhang, Xiao-feng Other Names: Qin Shuanglin Academic Editor. Journal: Journal of oncology Issue: Volume 2023(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study. (20th September 2022) Authors: Ma, Yuyu; Duan, Fangfang; Zhuang, Yue; Song, Chenge; Huang, Jiajia; Xia, Wen; Hong, Ruoxi; Zheng, Qiufan; Wang, Shusen; Shi, Yanxia; Xu, Fei; Yuan, Zhongyu; Bi, Xiwen Other Names: Qin Shuanglin Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗